These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Evaluation of the effects of verapamil, flunarizine, diltiazem, nimodipine and placebo in the prevention of hemicrania. A double-blind randomized cross-over study]. Paterna S; Martino SG; Campisi D; Cascio Ingurgio N; Marsala BA Clin Ter; 1990 Jul; 134(2):119-25. PubMed ID: 2147612 [TBL] [Abstract][Full Text] [Related]
5. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study. Diener HC; Bussone G; Van Oene JC; Lahaye M; Schwalen S; Goadsby PJ; Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of botulinum toxin type A for the prophylaxis of episodic migraine headaches: a meta-analysis of randomized, double-blind, placebo-controlled trials. Shuhendler AJ; Lee S; Siu M; Ondovcik S; Lam K; Alabdullatif A; Zhang X; Machado M; Einarson TR Pharmacotherapy; 2009 Jul; 29(7):784-91. PubMed ID: 19558252 [TBL] [Abstract][Full Text] [Related]
7. A double-blind placebo-controlled trial of indobufen in the prophylaxis of migraine. Carrieri PB; Orefice G; Sorge F Acta Neurol Scand; 1988 Jun; 77(6):433-6. PubMed ID: 3043994 [TBL] [Abstract][Full Text] [Related]
8. A double-blind, dose comparison study of topiramate for prophylaxis of basilar-type migraine in children: a pilot study. Lewis D; Paradiso E Headache; 2007; 47(10):1409-17. PubMed ID: 18052950 [TBL] [Abstract][Full Text] [Related]
10. Timolol vs propranolol vs placebo in common migraine prophylaxis: a double-blind multicenter trial. Tfelt-Hansen P; Standnes B; Kangasneimi P; Hakkarainen H; Olesen J Acta Neurol Scand; 1984 Jan; 69(1):1-8. PubMed ID: 6367336 [TBL] [Abstract][Full Text] [Related]
11. Nifedipine in the prophylaxis of classic migraine: a crossover, double-masked, placebo-controlled study of headache frequency and side effects. McArthur JC; Marek K; Pestronk A; McArthur J; Peroutka SJ Neurology; 1989 Feb; 39(2 Pt 1):284-6. PubMed ID: 2644581 [TBL] [Abstract][Full Text] [Related]
12. Naratriptan as short-term prophylaxis of menstrually associated migraine: a randomized, double-blind, placebo-controlled study. Newman L; Mannix LK; Landy S; Silberstein S; Lipton RB; Putnam DG; Watson C; Jöbsis M; Batenhorst A; O'Quinn S Headache; 2001 Mar; 41(3):248-56. PubMed ID: 11264684 [TBL] [Abstract][Full Text] [Related]
13. The impact of migraine on daily activities: effect of topiramate compared with placebo. Silberstein SD; Loder E; Forde G; Papadopoulos G; Fairclough D; Greenberg S Curr Med Res Opin; 2006 Jun; 22(6):1021-9. PubMed ID: 16846536 [TBL] [Abstract][Full Text] [Related]
14. Femoxetine in the prophylaxis of migraine--a randomised comparison with placebo. Zeeberg I; Orholm M; Nielsen JD; Honore PL; Larsen JJ Acta Neurol Scand; 1981 Dec; 64(6):452-9. PubMed ID: 6753446 [TBL] [Abstract][Full Text] [Related]
15. Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs. Dodick DW; Freitag F; Banks J; Saper J; Xiang J; Rupnow M; Biondi D; Greenberg SJ; Hulihan J; Clin Ther; 2009 Mar; 31(3):542-59. PubMed ID: 19393844 [TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled study. Dodick DW; Goadsby PJ; Spierings EL; Scherer JC; Sweeney SP; Grayzel DS Lancet Neurol; 2014 Sep; 13(9):885-92. PubMed ID: 25127173 [TBL] [Abstract][Full Text] [Related]